CareDx, Inc. (CDNA): Price and Financial Metrics

CareDx, Inc. (CDNA): $10.59

0.07 (+0.67%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

B

CDNA Price/Volume Stats

Current price $10.59 52-week high $12.93
Prev. close $10.52 52-week low $4.80
Day low $10.26 Volume 696,800
Day high $11.10 Avg. volume 979,441
50-day MA $9.70 Dividend yield N/A
200-day MA $9.08 Market Cap 548.34M

CDNA Stock Price Chart Interactive Chart >

CDNA POWR Grades

  • CDNA scores best on the Value dimension, with a Value rank ahead of 84.69% of US stocks.
  • The strongest trend for CDNA is in Sentiment, which has been heading up over the past 26 weeks.
  • CDNA ranks lowest in Growth; there it ranks in the 5th percentile.

CDNA Stock Summary

  • The ratio of debt to operating expenses for CAREDX INC is higher than it is for about just 14.65% of US stocks.
  • CDNA's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 15.54% of US stocks.
  • With a year-over-year growth in debt of -15.72%, CAREDX INC's debt growth rate surpasses merely 20.18% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to CAREDX INC are IGC, MXCT, LMND, HCP, and BASE.
  • Visit CDNA's SEC page to see the company's official filings. To visit the company's web site, go to www.caredx.com.

CDNA Valuation Summary

  • CDNA's price/earnings ratio is -7.2; this is 124.7% lower than that of the median Healthcare stock.
  • CDNA's price/sales ratio has moved down 2.1 over the prior 115 months.

Below are key valuation metrics over time for CDNA.

Stock Date P/S P/B P/E EV/EBIT
CDNA 2023-12-29 2.2 1.6 -7.2 -6.0
CDNA 2023-12-28 2.3 1.8 -7.7 -6.4
CDNA 2023-12-27 2.3 1.7 -7.6 -6.3
CDNA 2023-12-26 2.2 1.7 -7.4 -6.1
CDNA 2023-12-22 2.2 1.6 -7.1 -5.9
CDNA 2023-12-21 2.1 1.6 -7.0 -5.8

CDNA Growth Metrics

    The 4 year price growth rate now stands at 2271.96%.
  • The 4 year net income to common stockholders growth rate now stands at 42.57%.
  • Its 3 year revenue growth rate is now at 248.5%.
Over the past 33 months, CDNA's revenue has gone up $191,561,000.

The table below shows CDNA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 318.629 -28.258 -74.435
2022-06-30 314.859 -20.797 -69.393
2022-03-31 308.413 -7.132 -49.623
2021-12-31 296.397 -19.294 -30.662
2021-09-30 275.821 -16.279 -18.026
2021-06-30 253.601 -11.454 -8.947

CDNA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CDNA has a Quality Grade of C, ranking ahead of 63.01% of graded US stocks.
  • CDNA's asset turnover comes in at 0.543 -- ranking 49th of 81 Healthcare stocks.
  • MGLN, OPGN, and LH are the stocks whose asset turnover ratios are most correlated with CDNA.

The table below shows CDNA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.543 0.676 -0.174
2021-06-30 0.557 0.680 -0.105
2021-03-31 0.550 0.673 -0.201
2020-12-31 0.628 0.672 -0.382
2020-09-30 0.673 0.664 -0.802
2020-06-30 0.751 0.655 -1.009

CDNA Price Target

For more insight on analysts targets of CDNA, see our CDNA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $107.33 Average Broker Recommendation 1.36 (Strong Buy)

CareDx, Inc. (CDNA) Company Bio


CareDx, Inc. focuses on the discovery, development, and commercialization of diagnostic surveillance solutions for transplant patients in North America, Europe, the Middle East, Africa, and Latin America. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is based in Brisbane, California.


CDNA Latest News Stream


Event/Time News Detail
Loading, please wait...

CDNA Latest Social Stream


Loading social stream, please wait...

View Full CDNA Social Stream

Latest CDNA News From Around the Web

Below are the latest news stories about CAREDX INC that investors may wish to consider to help them evaluate CDNA as an investment opportunity.

CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication Adherence

BRISBANE, Calif., December 19, 2023--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it is joining forces with the National Foundation for Transplants (NFT) in offering its Transplant Pharmacy services to NFT patient members to help them manage the complexity of post-transplant medication adherence.

Yahoo | December 19, 2023

How Much Upside is Left in CareDx (CDNA)? Wall Street Analysts Think 26.72%

The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in CareDx (CDNA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Yahoo | December 8, 2023

Can CareDx (CDNA) Climb 29.79% to Reach the Level Wall Street Analysts Expect?

The mean of analysts' price targets for CareDx (CDNA) points to a 29.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Yahoo | November 22, 2023

CareDx, Inc (NASDAQ:CDNA) Q3 2023 Earnings Call Transcript

CareDx, Inc (NASDAQ:CDNA) Q3 2023 Earnings Call Transcript November 8, 2023 CareDx, Inc beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.38. Operator: Good day, everyone, and welcome to today’s CareDx Inc. Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity […]

Yahoo | November 10, 2023

CareDx Reports Third Quarter 2023 Results

BRISBANE, Calif., November 08, 2023--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today reported financial results for the third quarter ended September 30, 2023.

Yahoo | November 8, 2023

Read More 'CDNA' Stories Here

CDNA Price Returns

1-mo 8.95%
3-mo -11.75%
6-mo 51.29%
1-year 19.66%
3-year -83.18%
5-year -66.40%
YTD -11.75%
2023 5.17%
2022 -74.91%
2021 -37.23%
2020 235.88%
2019 -14.20%

Continue Researching CDNA

Want to see what other sources are saying about CareDx Inc's financials and stock price? Try the links below:

CareDx Inc (CDNA) Stock Price | Nasdaq
CareDx Inc (CDNA) Stock Quote, History and News - Yahoo Finance
CareDx Inc (CDNA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!